PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors that are being developed for the treatment of cancer. Both PD-1 and PD-L1 are proteins present on the cell surface. These immune checkpoint inhibitors are emerging as the first line of treatment for many types of cancer. PD-1 and PD-L1 Inhibitors market size is […]
